FREYR Battery (“FREYR”), a developer of clean, next-generation battery cell production capacity, has developed a program for the Environmental Impact Assessment (EIA) and submitted...
NRx Pharmaceuticals, a clinical-stage, biopharmaceutical company has received scientific evidence from the Israel Institute for Biological Research (IIBR) that the BriLife® vaccine may produce...
Dalriada Drug Discovery ("Dalriada") is pleased to announce a strategic collaboration with atai Life Sciences' N.V. newly launched platform company Invyxis, focused on developing...
